These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 12541428)

  • 1. [The rebound of nasal resistance after decongestant used in nose].
    Shen J; Huang X; Xiang J; Shu H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
    Yuta A; Ogawa Y
    Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhinitis medicamentosa as a cause of increased intraoperative bleeding.
    Robison JG; Pant H; Ferguson BJ
    Laryngoscope; 2010 Oct; 120(10):2106-7. PubMed ID: 20824778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhinitis medicamentosa: therapeutic effect of diode laser inferior turbinate reduction on nasal obstruction and decongestant abuse.
    Caffier PP; Frieler K; Scherer H; Sedlmaier B; Göktas O
    Am J Rhinol; 2008; 22(4):433-9. PubMed ID: 18702912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rhinitis medicamentosa: an increasing therapeutical problem].
    Betlejewski S
    Otolaryngol Pol; 1997; 51(1):53-7. PubMed ID: 9518316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhinitis medicamentosa.
    Ramey JT; Bailen E; Lockey RF
    J Investig Allergol Clin Immunol; 2006; 16(3):148-55. PubMed ID: 16784007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
    Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
    Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal septal perforation secondary to rhinitis medicamentosa.
    Keyserling HF; Grimme JD; Camacho DL; Castillo M
    Ear Nose Throat J; 2006 Jun; 85(6):376, 378-9. PubMed ID: 16866112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
    Archontaki M; Symvoulakis EK; Hajiioannou JK; Stamou AK; Kastrinakis S; Bizaki AJ; Kyrmizakis DE
    B-ENT; 2009; 5(3):159-62. PubMed ID: 19902852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Daily administration of nose drops can cause chronic nasal congestion].
    Graf P; Hallén H
    Lakartidningen; 1996 Jan; 93(4):259-62. PubMed ID: 8569350
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhinitis medicamentosa: what an otolaryngologist needs to know.
    Doshi J
    Eur Arch Otorhinolaryngol; 2009 May; 266(5):623-5. PubMed ID: 19096862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.